New approaches to blood and marrow transplantation for patients with low-grade lymphomas.
Low-grade lymphomas are generally considered incurable diseases with current standard therapies. Blood or marrow transplantation may be the exception. Nevertheless, the role of bone marrow transplantation in low-grade lymphomas has been limited by the usual indolent course of this heterogeneous group of diseases and the historically high rates of transplant-related mortality associated with most transplant procedures. This review discusses the current issues pertaining to bone marrow transplantation and comments on investigational approaches such as the use of monoclonal antibodies as in vivo purging mechanisms and nonmyeloablative and radioimmunoconjugated antibodies as alternate preparative regimens.
Berdeja
J G
JG
Johns Hopkins University, Department of Oncology, Division of Hematologic Malignancies, Baltimore, Maryland, USA.
Flinn
I W
IW
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000473:pathology / Q000628:therapy*; D011379:Prognosis
D000911:Antibodies, Monoclonal; D018796:Immunoconjugates